Online inquiry

IVTScrip™ mRNA-Human ANKRD39, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK18524MR)

This product GTTS-WK18524MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the ANKRD39 protein. This product can be used in Leydig cell-related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 1
Species Human
RefSeq NM_016466.6
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification Chromatography
Target Gene
Gene ID 51239
UniProt ID Q53RE8
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human ANKRD39, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK18524MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK28591MR IVTScrip™ mRNA-Human ARHGAP26, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ARHGAP26
GTTS-WK22935MR IVTScrip™ mRNA-Human ARL14, (Cap 0, 5-Methyl-CTP, 120 nt-poly(A)) mRNA ARL14
GTTS-WK9500MR IVTScrip™ mRNA-Human ADAMTS16, (Cap 0, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADAMTS16
GTTS-WK13147MR IVTScrip™ mRNA-Human ADGRL3, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ADGRL3
GTTS-WK21508MR IVTScrip™ mRNA-Human ANKRD20A4, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA ANKRD20A4
GTTS-WK21995MR IVTScrip™ mRNA-Human ARHGAP30, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARHGAP30
GTTS-WK20068MR IVTScrip™ mRNA-Human AOAH, (Cap 1, Pseudo-UTP, 30 nt-poly(A)) mRNA AOAH
GTTS-WK14105MR IVTScrip™ mRNA-Human 3C4, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA 3C4
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →